XML 26 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities      
Net income (loss) $ (493,927) $ (857,873) $ 583,201
Adjustments to reconcile net income to net cash flow from operating activities:      
Depreciation and amortization 547,990 611,067 634,305
Loss on impairment 121,639 1,458,749 418,298
Gain on extinguishment of debt, net 0 (17,814) 0
Deferred income taxes 241,326 (189,897) (36,172)
Amortization of share-based compensation 29,115 34,720 39,172
Other long-term asset write-off 29,032 0 0
Net change in other assets and liabilities (21,237) 87,124 126,103
Net cash provided by operating activities 453,938 1,126,076 1,764,907
Cash flows from investing activities      
Capital expenditures (111,140) (659,925) (422,544)
Change in accrued capital expenditures (46,830) (34,814) (14,607)
Proceeds from disposal of assets 2,382 24,808 4,614
Net cash used in investing activities (155,588) (669,931) (432,537)
Cash flows from financing activities      
Net change in borrowings outstanding on bank credit facilities 0 0 (1,123,495)
Issuance of senior notes 0 980,100 1,092,728
Repayments of debt (300,000) (1,049,338) (350,000)
Debt issuance costs on senior notes and credit facility (42) (12,111) (16,070)
Dividend payments 0 (47,534) (315,534)
Dividends paid to noncontrolling interests (56,881) (85,944) (71,504)
Repurchases of shares 0 0 (100,630)
Tender offer premium 0 (24,649) 0
Employee stock transactions (4,320) (3,192) (4,130)
Net cash used in financing activities (361,243) (242,668) (888,635)
Net increase (decrease) in cash and cash equivalents (62,893) 213,477 443,735
Cash and cash equivalents, beginning of period 725,722 512,245 68,510
Cash and cash equivalents, end of period 662,829 725,722 512,245
Noble Corp      
Cash flows from operating activities      
Net income (loss) (451,732) (828,007) 607,012
Adjustments to reconcile net income to net cash flow from operating activities:      
Depreciation and amortization 543,119 611,013 633,244
Loss on impairment 121,639 1,458,749 418,298
Gain on extinguishment of debt, net 0 (17,814) 0
Deferred income taxes 241,326 (189,897) (34,108)
Capital contribution by parent - share-based compensation 29,046 32,782 30,652
Other long-term asset write-off 29,030 0 0
Net change in other assets and liabilities (20,091) 89,445 92,409
Net cash provided by operating activities 492,337 1,156,271 1,747,507
Cash flows from investing activities      
Capital expenditures (111,140) (659,925) (422,544)
Change in accrued capital expenditures (46,830) (34,814) (14,607)
Proceeds from disposal of assets 2,382 24,808 4,614
Net cash used in investing activities (155,588) (669,931) (432,537)
Cash flows from financing activities      
Net change in borrowings outstanding on bank credit facilities 0 0 (1,123,495)
Issuance of senior notes 0 980,100 1,092,728
Repayments of debt (300,000) (1,049,338) (350,000)
Debt issuance costs on senior notes and credit facility (42) (12,111) (16,070)
Dividends paid to noncontrolling interests (56,881) (85,944) (71,504)
Tender offer premium 0 (24,649) 0
Contributions (distributions) from (to) parent company, net 28,352    
Contributions (distributions) from (to) parent company, net   (152,360) (400,614)
Net cash used in financing activities (328,571) (344,302) (868,955)
Net increase (decrease) in cash and cash equivalents 8,178 142,038 446,015
Cash and cash equivalents, beginning of period 653,833 511,795 65,780
Cash and cash equivalents, end of period $ 662,011 $ 653,833 $ 511,795